New 2026 Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1-viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT Group Practice Harmonisation and Guidelines Committee 1st listed author José Luis Piñana Journal EClinicalMedicine.
New 2026 Bridging to CD19 CAR T-cell therapy for large B-cell lymphoma: An analysis of 1,134 patients by the EBMT Lymphoma Working Party and the GoCART Coalition Group Lymphoma Working Party (LWP) GoCART Coalition 1st listed author Philipp Berning Journal Bone Marrow Transplant.
New 2026 Preparing HSCT and CAR‑T therapy programmes for JACIE inspection: a structured methodological approach to implementing a quality management system Group JACIE Working Party Inspector Committee Assurance Committee Quality Managers Committee 1st listed author Dimitrios Bourantas Journal Int J Qual Health Care.
New 2026 Cryopreservation of academic CAR T-cell products: methodological recommendations from the EBMT practice harmonisation and guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Halvard Bonig Journal Bone Marrow Transplant.
New 2026 Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party Group Lymphoma Working Party (LWP) Practice Harmonisation and Guidelines Committee 1st listed author Ali Bazarbachi Journal Lancet Haematol.
New 2026 Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working Party Group Lymphoma Working Party (LWP) 1st listed author Evgenii Shumilov Journal Hemasphere.
New 2026 Contemporary outcomes of salvage high-dose chemotherapy in advanced germ cell tumors: an analysis of the cellular therapy and immunobiology working party of the EBMT registry Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author V Tateo Journal ESMO Open.
New 2026 Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations for systemic treatments and allogeneic hematopoietic cell transplantation from the European Hematology Association, the EORTC Cutaneous Lymphoma Tumours Group, the International Society for Cutaneous Lymphoma, and the Lymphoma Working Party of the EBMT Group Lymphoma Working Party (LWP) Other society 1st listed author Francesco Onida Journal Hemasphere.
New 2026 Correction: Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Jesús Duque-Afonso Journal Bone Marrow Transplant.
New 2026 Non-culture based diagnostic tests for detection of bacterial infections in hematology patients with febrile neutropenia: A review by the European Conference on Infections in Leukemia (ECIL-10) Group Infectious Diseases Working Party (IDWP) Other society 1st listed author Dionysios Neofytos Journal Curr Res Transl Med.
New 2026 Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Giorgio Orofino Journal EClinicalMedicine.
New 2026 TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT Group Inborn Errors Working Party (IEWP) 1st listed author Giulia Prunotto Journal J Hum Immun.